RT @msh_manu: @fluidloading @thomaswoodcock @yourICM @ClinMedJournals @dr_manuweiss @Dr_Cit @ESICM 🤣.. It’s about the potential differences…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
.@ACHETI2017
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
RT @yourICM: Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find…
Polymyxin B hemoperfusion: still a benefit in mortality for patients with severe septic shock and high endotoxin levels? Find out for free at https://t.co/WHHEvR40Cn #openaccess @Dr_Cit @ESICM @ClinMedJournals https://t.co/0Kaf0oMxw1
Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial https://t.co/8DGvzabhew #IntCareMed